2-(4-bromophenyl)-4-methyl-5-[4-[1-[(4-methylphenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-1,3-thiazole
C29H23BrN6S — CID 155525042
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-bromophenyl)-4-methyl-5-[4-[1-[(4-methylphenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-1,3-thiazole
2-(4-bromophenyl)-4-methyl-5-[4-[1-[(4-methylphenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-1,3-thiazole (PubChem CID 155525042) has the molecular formula C29H23BrN6S and a molecular weight of 567.52 g/mol. Its IUPAC name is 2-(4-bromophenyl)-4-methyl-5-[4-[1-[(4-methylphenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-1,3-thiazole.
Molecular Properties
| Compound Name | 2-(4-bromophenyl)-4-methyl-5-[4-[1-[(4-methylphenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-1,3-thiazole |
|---|---|
| PubChem CID | 155525042 |
| Molecular Formula | C29H23BrN6S |
| Molecular Weight | 567.52 g/mol |
| Exact Mass | 566.09 |
| IUPAC Name | 2-(4-bromophenyl)-4-methyl-5-[4-[1-[(4-methylphenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-1,3-thiazole |
| SMILES | Cc1ccc(Cn2cc(-c3cn(-c4ccccc4)nc3-c3sc(-c4ccc(Br)cc4)nc3C)nn2)cc1 |
| InChI | InChI=1S/C29H23BrN6S/c1-19-8-10-21(11-9-19)16-35-18-26(32-34-35)25-17-36(24-6-4-3-5-7-24)33-27(25)28-20(2)31-29(37-28)22-12-14-23(30)15-13-22/h3-15,17-18H,16H2,1-2H3 |
| InChIKey | ABXGFULIVVWLMV-UHFFFAOYSA-N |
| XLogP | 7.35 |
| TPSA | 61.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 567.52 |
| LogP ≤ 5 | 7.35 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155525042 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.